Pnc Financial Services Group, Inc. Anebulo Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $153 Billion
- Q2 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,528 shares of ANEB stock, worth $3,636. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,528Holding current value
$3,636% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANEB
# of Institutions
21Shares Held
22.6MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$36.8 Million18.74% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$7.23 Million0.18% of portfolio
-
Mangrove Partners New York, NY2.53MShares$6.01 Million0.52% of portfolio
-
Morgan Stanley New York, NY399KShares$950,1410.0% of portfolio
-
Lvw Advisors, LLC350KShares$832,0880.06% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $61M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...